Cramer says look to these 4 stocks to go with your high-flying tech names

3 hours ago

Regeneron inks drug pricing deal with Trump, will offer hearing-loss therapy for free

3 hours ago

Trump admin moves to reclassify cannabis in shift that could expand research

7 hours ago

RFK Jr. says he would support a potential ban on junk food TV ads

1 day ago

Amazon launches GLP-1 weight loss program, promising 'fast, convenient' access

2 days ago

UnitedHealth Group tops quarterly estimates, hikes profit outlook

2 days ago

How Trump's psychedelics executive order could unlock stalled cannabis reform

3 days ago

Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7 billion

3 days ago

After a rare disease left her paralyzed, she's running the Boston Marathon

3 days ago

Naomi Watts' menopause message: 'Why is it so taboo when we are half population'

3 days ago

Trump nominates Erica Schwartz as CDC director

7 days ago

Here's our monthly update on all 31 portfolio stocks, including 3 on the buy list

7 days ago

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves

7 days ago

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount

9 days ago

Revolution Medicines says its pancreatic cancer drug succeeds in late-stage trial

9 days ago

A mom tech entrepreneur building AI advocate for rare-disease families like hers

10 days ago

Trump policies, China's biotech boom are ending Europe's pharma powerhouse era

12 days ago

Former senator shines spotlight on a possible breakthrough for pancreatic cancer

12 days ago

CNBC Cures: A doctor dad on how raising child with Angelman syndrome changed him

13 days ago

Novo Nordisk's Wegovy pill launch draws a new wave of patients into GLP-1s

14 days ago

Trump admin finalizes better-than-feared Medicare Advantage payment rate

16 days ago

FDA declines to issue specific guidance on health programs' foreign drug imports

17 days ago

Trump administration sets up to 100% tariffs on some imported drugs

17 days ago

Novo Nordisk says Wegovy pill outperforms Lilly's oral GLP-1 in cross-trial comparison

21 days ago

Eli Lilly opposes White House push to codify most favored nation drug pricing

21 days ago

FDA approves Eli Lilly's GLP-1 pill, opening next phase for weight loss drugs

22 days ago

Stocks soar on hopes of war resolution — plus, Lilly takes a swing in sleep disorders

22 days ago

Lilly to spend up to $7.8 billion to acquire Centessa, sleep disorder drugmaker

23 days ago

Novo Nordisk launches Wegovy subscriptions as it tries to catch up with Eli Lilly

23 days ago

Eli Lilly reaches deal to bring AI-developed drugs to global market

23 days ago

AstraZeneca stock jumps after surprise lung disease trial win

25 days ago

Pfizer to seek approval for Lyme disease vaccine candidate despite trial miss

27 days ago